Cintas Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Cintas wird ein jährliches Gewinn- und Umsatzwachstum von 8.5% bzw. 6.9% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 8.2% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 34% betragen.
Wichtige Informationen
8.5%
Wachstumsrate der Gewinne
8.6%
EPS-Wachstumsrate
Commercial Services Gewinnwachstum | 14.7% |
Wachstumsrate der Einnahmen | 6.6% |
Zukünftige Eigenkapitalrendite | 33.2% |
Analystenabdeckung | Good |
Zuletzt aktualisiert | 20 Aug 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is Cintas Corporation (NASDAQ:CTAS) Potentially Undervalued?
Aug 22Cintas (NASDAQ:CTAS) Is Increasing Its Dividend To $1.56
Aug 01Is Cintas (NASDAQ:CTAS) Using Too Much Debt?
Jun 27Cintas Corporation (NASDAQ:CTAS) Shares Could Be 31% Above Their Intrinsic Value Estimate
Jun 14Cintas: Economic Profit Is Underappreciated, Not As Pricey As It Appears
Jun 13Cintas: More Dangerous Overvaluation
Jun 07Should You Be Adding Cintas (NASDAQ:CTAS) To Your Watchlist Today?
Jun 02We Think Cintas (NASDAQ:CTAS) Might Have The DNA Of A Multi-Bagger
May 21Earnings Not Telling The Story For Cintas Corporation (NASDAQ:CTAS)
Apr 22Cintas Corporation: Shares Have Risen Too High (Rating Downgrade)
Mar 28Should You Investigate Cintas Corporation (NASDAQ:CTAS) At US$628?
Mar 20Cintas (NASDAQ:CTAS) Has A Rock Solid Balance Sheet
Mar 07With EPS Growth And More, Cintas (NASDAQ:CTAS) Makes An Interesting Case
Feb 22Shareholders Would Enjoy A Repeat Of Cintas' (NASDAQ:CTAS) Recent Growth In Returns
Feb 05Cintas Corporation: I Am Still Positive
Jan 13Cintas Corporation (NASDAQ:CTAS) Investors Are Less Pessimistic Than Expected
Dec 27Do Cintas' (NASDAQ:CTAS) Earnings Warrant Your Attention?
Nov 21Is Cintas (NASDAQ:CTAS) Using Too Much Debt?
Nov 08Investors Should Be Encouraged By Cintas' (NASDAQ:CTAS) Returns On Capital
Oct 28At US$517, Is It Time To Put Cintas Corporation (NASDAQ:CTAS) On Your Watch List?
Oct 17Cintas Corporation (NASDAQ:CTAS) Shares Could Be 28% Above Their Intrinsic Value Estimate
Sep 25Here's Why We Think Cintas (NASDAQ:CTAS) Might Deserve Your Attention Today
Aug 05Returns on Capital Paint A Bright Future For Cintas (NASDAQ:CTAS)
Jul 25We Think Cintas (NASDAQ:CTAS) Can Manage Its Debt With Ease
Jul 14What Does Cintas Corporation's (NASDAQ:CTAS) Share Price Indicate?
Jul 03Are Cintas Corporation (NASDAQ:CTAS) Investors Paying Above The Intrinsic Value?
Jun 20With EPS Growth And More, Cintas (NASDAQ:CTAS) Makes An Interesting Case
May 05Why The 25% Return On Capital At Cintas (NASDAQ:CTAS) Should Have Your Attention
Apr 09Is It Time To Consider Buying Cintas Corporation (NASDAQ:CTAS)?
Mar 28Does Cintas (NASDAQ:CTAS) Have A Healthy Balance Sheet?
Mar 16Here's Why Cintas (NASDAQ:CTAS) Has Caught The Eye Of Investors
Jan 27Calculating The Fair Value Of Cintas Corporation (NASDAQ:CTAS)
Jan 04Cintas (NASDAQ:CTAS) Is Very Good At Capital Allocation
Dec 24Is Now The Time To Look At Buying Cintas Corporation (NASDAQ:CTAS)?
Dec 13These 4 Measures Indicate That Cintas (NASDAQ:CTAS) Is Using Debt Safely
Oct 14Do Cintas' (NASDAQ:CTAS) Earnings Warrant Your Attention?
Oct 03Cintas Q1 2023 Earnings Preview
Sep 27Gewinn- und Umsatzwachstumsprognosen
Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
---|---|---|---|---|---|
5/31/2027 | 11,797 | 2,053 | 2,088 | 2,553 | 8 |
5/31/2026 | 11,005 | 1,887 | 1,905 | 2,342 | 17 |
5/31/2025 | 10,276 | 1,719 | 1,734 | 2,129 | 18 |
5/31/2024 | 9,597 | 1,566 | 1,670 | 2,080 | N/A |
2/29/2024 | 9,410 | 1,498 | 1,526 | 1,940 | N/A |
11/30/2023 | 9,194 | 1,426 | 1,323 | 1,708 | N/A |
8/31/2023 | 8,992 | 1,376 | 1,269 | 1,637 | N/A |
5/31/2023 | 8,816 | 1,343 | 1,267 | 1,598 | N/A |
2/28/2023 | 8,606 | 1,291 | 1,296 | 1,595 | N/A |
11/30/2022 | 8,377 | 1,280 | 1,285 | 1,563 | N/A |
8/31/2022 | 8,124 | 1,250 | 1,312 | 1,574 | N/A |
5/31/2022 | 7,854 | 1,230 | 1,297 | 1,538 | N/A |
2/28/2022 | 7,615 | 1,203 | 1,234 | 1,443 | N/A |
11/30/2021 | 7,432 | 1,145 | 1,187 | 1,382 | N/A |
8/31/2021 | 7,267 | 1,135 | 1,149 | 1,311 | N/A |
5/31/2021 | 7,116 | 1,103 | 1,217 | 1,361 | N/A |
2/28/2021 | 6,900 | 981 | 1,120 | 1,262 | N/A |
11/30/2020 | 6,934 | 957 | 1,131 | 1,293 | N/A |
8/31/2020 | 7,021 | 917 | 1,130 | 1,327 | N/A |
5/31/2020 | 7,085 | 868 | 1,061 | 1,291 | N/A |
2/29/2020 | 7,259 | 950 | 1,073 | 1,332 | N/A |
11/30/2019 | 7,131 | 916 | 1,029 | 1,295 | N/A |
8/31/2019 | 7,005 | 912 | 905 | 1,182 | N/A |
5/31/2019 | 6,892 | 873 | 791 | 1,068 | N/A |
2/28/2019 | 6,768 | 836 | 691 | 974 | N/A |
11/30/2018 | 6,675 | 928 | 653 | 930 | N/A |
8/31/2018 | 6,563 | 824 | 599 | 873 | N/A |
5/31/2018 | 6,477 | 772 | 692 | 964 | N/A |
2/28/2018 | 6,337 | 665 | N/A | 941 | N/A |
11/30/2017 | 6,004 | 489 | N/A | 841 | N/A |
8/31/2017 | 5,668 | 474 | N/A | 861 | N/A |
5/31/2017 | 5,323 | 449 | N/A | 764 | N/A |
2/28/2017 | 4,955 | 476 | N/A | 652 | N/A |
11/30/2016 | 4,916 | 477 | N/A | 503 | N/A |
8/31/2016 | 4,864 | 470 | N/A | 480 | N/A |
5/31/2016 | 4,796 | 441 | N/A | 466 | N/A |
2/29/2016 | 4,777 | 433 | N/A | 500 | N/A |
11/30/2015 | 4,669 | 417 | N/A | 553 | N/A |
8/31/2015 | 4,574 | 406 | N/A | 575 | N/A |
5/31/2015 | 4,370 | 399 | N/A | 580 | N/A |
2/28/2015 | 4,469 | 433 | N/A | 598 | N/A |
11/30/2014 | 4,471 | 417 | N/A | 676 | N/A |
8/31/2014 | 4,471 | 399 | N/A | 672 | N/A |
5/31/2014 | 4,194 | 335 | N/A | 606 | N/A |
2/28/2014 | 4,464 | 331 | N/A | 570 | N/A |
11/30/2013 | 4,429 | 321 | N/A | 548 | N/A |
8/31/2013 | 4,365 | 314 | N/A | 540 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: CTASDas prognostizierte Gewinnwachstum (8.5% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: CTASDie Erträge des Unternehmens (8.5% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (14.8% pro Jahr).
Hohe Wachstumserträge: CTASDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: CTASDie Einnahmen des Unternehmens (6.9% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: CTASDie Einnahmen des Unternehmens (6.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: CTASDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (34%)